Impact of Empagliflozin on Subclinical Left Ventricular Dysfunctions and on the Mechanisms Involved in Myocardial Disease Progression in Type 2 Diabetes: Rationale and Design of the Empa-Heart Trial

AuthID
 P-015-CM7
5
Author(s)
Nesti L.
·
Fabiani I.
·
Calogero E.
·
Di Bello V.
Document Type
Article
Year published
2017
Published
in Cardiovascular Diabetology
Volume: 16, Issue: 1
Indexing
Scopus®
Crossref®39
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 29025406
SCOPUS: 2-s2.0-85030834144
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service